G Sutherland

2.3k total citations
42 papers, 1.8k citations indexed

About

G Sutherland is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, G Sutherland has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 14 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in G Sutherland's work include Smoking Behavior and Cessation (23 papers), Nicotinic Acetylcholine Receptors Study (12 papers) and Obesity, Physical Activity, Diet (5 papers). G Sutherland is often cited by papers focused on Smoking Behavior and Cessation (23 papers), Nicotinic Acetylcholine Receptors Study (12 papers) and Obesity, Physical Activity, Diet (5 papers). G Sutherland collaborates with scholars based in United Kingdom, Bulgaria and Australia. G Sutherland's co-authors include J A Stapleton, Michael A. Russell, John Stapleton, C Feyerabend, Saman Warnakulasuriya, Crispian Scully, S. Rachman, Michael Belcher, Peter Hájek and M. J. Jarvis and has published in prestigious journals such as The Lancet, American Journal of Public Health and Thorax.

In The Last Decade

G Sutherland

42 papers receiving 1.7k citations

Peers

Countries citing papers authored by G Sutherland

Since Specialization

Citations

This map shows the geographic impact of G Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Sutherland more than expected).

Fields of papers citing papers by G Sutherland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Sutherland. The network helps show where G Sutherland may publish in the future.

Co-authorship network of co-authors of G Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of G Sutherland. A scholar is included among the top collaborators of G Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Sutherland. G Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Smoking and its treatment in addiction services: Clients’ and staff behaviour and attitudes 2014 ·BMC Health Services Research ·(unknown), John Strang, Elena Ratschen, G Sutherland, Emily Finch, Ann McNeill	73
2	Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy 2011 ·Pharmacogenetics and Genomics ·John Stapleton, G Sutherland, Colin OʼGara, (unknown), David Ball	22
3	Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo‐controlled trial 2010 ·Addiction ·John Stapleton, G Sutherland	26
4	Illicit drug use as a predictor of smoking cessation treatment outcome 2009 ·Nicotine & Tobacco Research ·John Stapleton, Francis Keaney, G Sutherland	33
5	Association of the serotonin transporter gene, neuroticism and smoking behaviours 2008 ·Journal of Human Genetics ·Colin OʼGara, Jo Knight, John Stapleton, Jason Luty, Ben Neale, (unknown), (unknown), Farzana Hoda, Sarah Cohen‐Woods, G Sutherland, David Collier, Pak C. Sham, David Ball, Peter McGuffin, Ian Craig	13
6	Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment 2007 ·Pharmacogenetics and Genomics ·Colin OʼGara, John Stapleton, G Sutherland, Camila Guindalini, Ben Neale, Gerome Breen, David Ball	38
7	GENETIC STUDY: Association between dopamine transporter genotypes and smoking cessation: a meta‐analysis 2007 ·Addiction Biology ·John Stapleton, G Sutherland, Colin OʼGara	32
8	Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness 2007 ·Addiction ·John Stapleton, (unknown), (unknown), Robert C. Smith, (unknown), (unknown), G Sutherland	158
9	Who Calls QUIT®? The characteristics of smokers seeking advice via a telephone helpline compared with smokers attending a clinic and those in the general population 2005 ·Public Health ·Hazel Gilbert, Stephen Sutton, G Sutherland	36
10	Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile 2003 ·Addiction Biology ·José Martı́nez-Raga, Francis Keaney, G Sutherland, (unknown), John Strang	23
11	Current Approaches to the Management of Smoking Cessation 2002 ·Drugs ·G Sutherland	29
12	SMOKING CESSATION: A CONSENSUS STATEMENT WITH SPECIAL REFERENCE TO PRIMARY CARE 2001 ·International Journal of Clinical Practice ·Graham Jackson, (unknown), (unknown), G. Herbert Fowler, (unknown), (unknown), (unknown), J A Stapleton, (unknown), Paula L. Stillman, G Sutherland, (unknown)	9
13	Dramatic Decline in Circulating Intercellular Adhesion Molecule-1 Concentration on Quitting Tobacco Smoking 2000 ·Blood Cells Molecules and Diseases ·David A. Scott, John Stapleton, Ron Wilson, G Sutherland, Richard Palmer, P Y Coward, G Gustavsson	40
14	How much does relapse after one year erode effectiveness of smoking cessation treatments? Long term follow up of randomised trial of nicotine nasal spray 1998 ·BMJ ·J A Stapleton, G Sutherland, Michael A. Russell	47
15	Naltrexone, smoking behaviour and cigarette withdrawal 1995 ·Psychopharmacology ·G Sutherland, J A Stapleton, Michael A. Russell, C Feyerabend	79
16	Plenary lectures 1992 ·G Sutherland, R. Nick Bryan	1
17	Randomised controlled trial of nasal nicotine spray in smoking cessation 1992 ·The Lancet ·G Sutherland, J A Stapleton, Michael A. Russell, M. J. Jarvis, Peter Hájek, Michael Belcher, C Feyerabend	227
18	Nasal nicotine spray: a rapid nicotine delivery system 1992 ·Psychopharmacology ·G Sutherland, Michael A. Russell, J A Stapleton, C Feyerabend, (unknown)	60
19	Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study 1989 ·Psychopharmacology ·Peter Hájek, M. J. Jarvis, Michael Belcher, G Sutherland, C Feyerabend	36
20	Nicotine absorption and dependence in an over the counter aid to stopping smoking. 1989 ·BMJ ·Michael Belcher, M. J. Jarvis, G Sutherland	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact